Redefining Patient Selection Strategies with Liquid Biopsies to Revolutionize Patient Safety in Clinical Trials
Time: 2:30 pm
day: Day One Track B (1)
Details:
- Harnessing ctDNA to provide novel biomarker insights for improved patient selection
- Integrating molecular insights into patient selection strategies
- Understanding the commercial advantages of improved patient selection
